Dylan Cease Is Making Blue Jays Fans Feel Great About This Signing

Dylan Cease's remarkable season with the Blue Jays is proving skeptics wrong and solidifying his status as one of the franchise's best-ever signings.

The Blue Jays didn’t just buy a pitcher when they gave Dylan Cease a seven-year, $210 million deal. They bought the kind of arm that can carry a rotation, and Sunday’s one-hit shutout of the Boston Red Sox was the clearest reminder yet that Toronto got that call right.

There were plenty of questions when the contract was announced after Cease posted a 4.55 ERA with the San Diego Padres. But the numbers beneath that surface told a different story, one that suggested a rebound was coming.

Toronto bet on the stuff, the track record, and the upside that had once put Cease in the top five of Cy Young voting twice. So far in 2026, that bet has looked brilliant.

Cease has pushed his ERA down to 2.46 after his latest gem at Fenway Park. He leads the American League with 167 strikeouts even though he missed two starts because of a hamstring issue. His 2.31 FIP and 6.0 hits per nine innings also lead the Junior Circuit.

The underlying profile is just as loud. Cease sits in the 93rd percentile or better in xERA, expected batting average, average exit velocity, whiff percentage and K-rate. He’s still missing bats at an elite clip, but he’s also added something new by getting ground balls at an above-average rate for the first time in his career.

That performance has already earned him his long-awaited All-Star nod, and he became the first Blue Jay since Roy Halladay to start the game. Now the focus turns to the Cy Young race, where he’s in what the source describes as an epic battle with New York Yankees ace Cam Schlittler down the stretch.

For Toronto, Cease’s value goes beyond one dominant season. He’s the most talented pitcher the Blue Jays have had since Halladay, and he could end up challenging Kevin Gausman as the best free-agent signing in franchise history.

There’s always risk on the back end of a long deal, and the source points to Gausman’s current season as the kind of thing that can happen. But that’s the tradeoff when a front office stretches the term to land the player it wants in free agency.

Cease also stands out when stacked against the other big-name pitchers from his free-agent class. Framber Valdez has a 4.57 ERA for the Detroit Tigers.

Ranger Suarez has pitched well for the Red Sox but missed time with an injury. Michael King’s strikeout rate has dropped for the San Diego Padres.

By that measure, Cease has been the best of the group.

Toronto needed an ace after its run to the World Series in 2025, and Cease has given them exactly that. Even with the team around him falling apart, he has been everything the Blue Jays hoped for when they made the move.

In Other News...

Blue Jays Just Took Another Brutal Injury Hit Into 2027

Addison Bargers season has already been a grind, and now it is headed for an abrupt end. The Blue Jays infielder will need elbow surgery after a year that never really got off the ground, another frustrating turn in a stretch defined by one setback after another for a roster that has struggled to keep key pieces on the field.

Barger is hardly alone in that reality. Cody Ponce, Anthony Santander, Jos Berros and Bowden Francis are all dealing with injuries that will shape Torontos availability the rest of 2026 and could linger into 2027, leaving the club with more uncertainty than answers as it tries to map out its next steps. For a team trying to stay competitive, the health picture has become as important as anything happening on the field. [Read more 🡒]

Blue Jays Fans Still Cannot Believe How Far Alek Manoah Fell

Alek Manoahs rise once looked like one of the Blue Jays biggest developmental wins of the past decade. Drafted 11th overall in 2019, he broke through in 2021 with a strong rookie season, then took another step in 2022 by making the All-Star team and finishing third in AL Cy Young voting. For Toronto fans, he went from promising arm to front-line starter in a hurry, which made the collapse that followed all the harder to process.

The downturn began in the 2022 postseason and never really let up, with struggles carrying through 2023 and 2024 as injuries piled on and Tommy John surgery entered the picture. Toronto eventually designated him for assignment in 2025, and his move to the Los Angeles Angels was supposed to offer a reset, but the results have remained uneven and he has already been sent to Triple-A after another rough stretch. For a pitcher who once seemed destined to anchor the rotation, the question now is less about upside than how much runway is left. [Read more 🡒]

Blue Jays May Be Headed For A Deadline Decision Fans Dread

With the trade deadline still a long way off, the Blue Jays are already staring at a familiar kind of front-office dilemma: whether to chase a win-now path by moving established names or try to keep the group intact and sort out long-term plans later. Kevin Gausman, Shane Bieber and Daulton Varsho all sit in the middle of that conversation, and each brings a different type of value that would make him attractive if Toronto ever decided to listen.

Bieber, in particular, has given the Jays another reason to think carefully about what comes next, with his recent stretch showing enough stability to keep him in the spotlight. Varshos power and defensive profile also make him the sort of player contenders would circle quickly, which is why the possibility of Toronto choosing extensions over a reset feels like the real hinge point here. The question is not whether these names would draw interest, but whether the Blue Jays want to be the team that has to answer it. [Read more 🡒]